What effect will the newest member of the Board of the University of Arkansas System have on litigation against the Board and UAMS?

“Ashley Caldwell is the senior director of strategic accounts at Embecta Corp., where she leads retail, marketing and distribution partnerships to deliver healthcare solutions in the diabetes industry.” This is quoted from the university website, under the board members’ profile page.

I don’t know how long Ms. Caldwell has been working for Embecta or her role in the stock plummeting to less than a quarter of its price over the last five years. And I don’t know how much business is transacted between the company and UAMS. But I will find out and let y’all know.